We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  3. null/null
  4. 4 キャタレント・ジャパン Tokyo//Manufacturing and processing contract
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  3. Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Pharmaceutical CDMO services 大塚化学

medicine Product List

301～315 item / All 516 items

Displayed results
[Research Material] The Global Market for Prescription Dermatological Treatments

[Research Material] The Global Market for Prescription Dermatological Treatments

Global Market for Prescription Dermatological Treatments: Antifungal Drugs, Skin Cancer Drugs, Acne & Rosacea Drugs, Psoriasis Drugs, Dermatitis & Seborrheic Drugs, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Prescription Dermatology Therapeutics Market) investigates and analyzes the current state and outlook for the global prescription dermatology therapeutics market over the next five years. It includes information on the overview of the global prescription dermatology therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the prescription dermatology therapeutics market include antifungal medications, skin cancer drugs, acne & rosacea medications, psoriasis treatments, and dermatitis & seborrheic dermatitis medications. The segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for prescription dermatology therapeutics. It also includes the market share of major companies in prescription dermatology therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

[Research Material] Global Market for Trigeminal Neuralgia Treatment Drugs

Global Market for Trigeminal Neuralgia Treatment Drugs: Carbamazepine, Oxcarbazepine, Others, Hospitals, Clinics, Others

This research report (Global Trigeminal Neuralgia Treatment Medicine Market) investigates and analyzes the current status and outlook for the global market for trigeminal neuralgia treatment medications over the next five years. It includes information on the overview of the global trigeminal neuralgia treatment medication market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include carbamazepine, oxcarbazepine, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for trigeminal neuralgia treatment medications. It also includes the market share of major companies in the trigeminal neuralgia treatment medication sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Autoimmune Hepatitis Treatment

[Research Material] Global Market for Autoimmune Hepatitis Treatment

Global Market for Autoimmune Hepatitis Treatment: Tablets, Injections, Others, Hospitals, Clinics, Others

This research report (Global Autoimmune Hepatitis Treatment Market) investigates and analyzes the current status and outlook for the global autoimmune hepatitis treatment market over the next five years. It includes information on the overview of the global autoimmune hepatitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments of the autoimmune hepatitis treatment market by type include tablets, injectables, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for autoimmune hepatitis treatment. It also includes the market share of major companies in autoimmune hepatitis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for White Matter Injury Treatment

[Research Material] Global Market for White Matter Injury Treatment

Global Market for White Matter Injury Treatment: Drug Therapy, Palliative Care, Hospitals, Emergency Centers, Outpatient Surgery Centers, Others

This research report (Global White Matter Injury Treatment Market) investigates and analyzes the current status and outlook for the global market for white matter injury treatment over the next five years. It includes information on the overview of the global white matter injury treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include drug treatment and palliative care, while the segments by application focus on hospitals, emergency centers, outpatient surgery centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for white matter injury treatment. It also includes the market share of major companies in white matter injury treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Materials] Global Market for Purpura Treatment Drugs

[Research Materials] Global Market for Purpura Treatment Drugs

World Market for Purpura Treatments: Allergic Purpura, Thrombocytopenic Purpura, Hospital Use, Clinic Use, Home Use, Others

This research report (Global Purpura Therapy Drugs Market) investigates and analyzes the current status and outlook for the global market of purpura treatment drugs over the next five years. It includes information on the overview of the global purpura treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on allergic purpura and thrombocytopenic purpura, while the segments by application target hospitals, clinics, home use, and others. The regional segments calculate the market size of purpura treatment drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in purpura treatment drugs, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Knee Treatment in Athletes

[Research Material] Global Market for Knee Treatment in Athletes

World Market for Athlete Knee Treatments: Corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Hyaluronic Acid, Others, Hospitals, Clinics ...

This research report (Global Athletic Knee Treatment Market) investigates and analyzes the current state and outlook for the global market for athlete knee treatments over the next five years. It includes information on the overview of the global athlete knee treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs), hyaluronic acid, and others, while the segments by application cover hospitals, clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for athlete knee treatments. It also includes the market share of major companies in athlete knee treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rheumatic Disease Therapeutics

[Research Material] Global Market for Rheumatic Disease Therapeutics

World Market for Rheumatic Disease Therapeutics: Tumor Necrosis Factor-α Inhibitors, Interleukin and Interleukin Receptor Inhibitors, Protein Kinase ...

This research report (Global Rheumatic Disorders Drug Market) investigates and analyzes the current state and outlook for the global market for rheumatic disease treatment drugs over the next five years. It includes information on the overview of the global rheumatic disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the rheumatic disease treatment drug market include tumor necrosis factor-alpha inhibitors, interleukin and interleukin receptor inhibitors, protein kinase inhibitors, cell surface antigen inhibitors, hormone and hormone receptor inhibitors, and others. The segments by application include rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, psoriatic arthritis, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for rheumatic disease treatment drugs. It also includes the market share of major companies in the rheumatic disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

[Research Document] Global Market for Treatment Drugs for Undifferentiated Large Cell Lymphoma

World Market for Undifferentiated Large Cell Lymphoma Treatment Drugs: Oral, Injection, Hospitals, Drugstores, Others

This research report (Global Anaplastic Large Cell Lymphoma Drugs Market) investigates and analyzes the current status and outlook for the global market of anaplastic large cell lymphoma treatment drugs over the next five years. It includes information on the overview of the global anaplastic large cell lymphoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis, among other details. The market segments by type focus on oral and injectable forms, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for anaplastic large cell lymphoma treatment drugs. It also includes the market share of major companies in the anaplastic large cell lymphoma treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

[Research Material] Global Market for Primary Sclerosing Cholangitis Treatment

Global Market for Primary Sclerosing Cholangitis Treatment: Liver Transplant Surgery, UDCA Drugs, PSC Drugs, Hospitals, Clinics, Others

This research report (Global Primary Sclerosing Cholangitis Treatment Market) investigates and analyzes the current state and outlook for the global market for primary sclerosing cholangitis treatment over the next five years. It includes information on the overview of the global primary sclerosing cholangitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the primary sclerosing cholangitis treatment market focus on liver transplant surgery, UDCA drugs, and PSC drugs, while the segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for primary sclerosing cholangitis treatment. It also includes the market share of major companies in primary sclerosing cholangitis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for the Treatment of Tardive Dyskinesia (TD)

[Research Material] The Global Market for the Treatment of Tardive Dyskinesia (TD)

World Market for the Treatment of Tardive Dyskinesia (TD): Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Others, Hospitals, Clinics, Others

This research report (Global Tardive Dyskinesia (TD) Treatment Market) investigates and analyzes the current state and future outlook of the global market for tardive dyskinesia (TD) treatment over the next five years. It includes information on the overview of the global tardive dyskinesia (TD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include valbenazine, amantadine, tetrabenazine, clonazepam, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for tardive dyskinesia (TD) treatment. It also includes the market share of major companies in the tardive dyskinesia (TD) treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for ALK-Positive Lung Cancer Treatment

[Research Material] The Global Market for ALK-Positive Lung Cancer Treatment

Global Market for ALK Positive Lung Cancer Treatment: Crizotinib, Alectinib, Ceritinib, Brigatinib, Others, Hospitals, Clinics, Others

This research report (Global ALK Positive Lung Cancer Treatment Market) investigates and analyzes the current state and outlook for the global market for ALK-positive lung cancer treatment over the next five years. It includes information on the overview of the global ALK-positive lung cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ALK-positive lung cancer treatment market include crizotinib, alectinib, ceritinib, brigatinib, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments calculate the market size for ALK-positive lung cancer treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in ALK-positive lung cancer treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Bone and Mineral Metabolism Disorder Treatment

[Research Material] Global Market for Bone and Mineral Metabolism Disorder Treatment

Global Market for Treatment of Bone and Mineral Metabolism Disorders: Bisphosphonates, Estrogens, Phosphate Binders, Non-Calcium, Non-Metal Binders, Metal...

This research report (Global Bone and Mineral Metabolism Disorders Treat) investigates and analyzes the current state and outlook for the global market for bone and mineral metabolism disorder treatments over the next five years. It includes information on the overview of the global bone and mineral metabolism disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments of the bone and mineral metabolism disorder treatment market by type include bisphosphonates, estrogens, phosphate binders, non-calcium, non-metal binders, metal binders, magnesium binders, vitamin D analogs and supplements, calcium mimetics, and calcium-magnesium supplements. The segments by application target hospital pharmacies, retail pharmacies, online pharmacies, and drugstores. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for bone and mineral metabolism disorder treatments.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

[Research Material] Global Market for Treatment of Acquired Cystic Kidney Disease

World Market for Treatment of Acquired Cystic Kidney Disease: Antibiotics, Non-Steroidal Anti-Inflammatory Drugs, Others, Hospitals, Clinics, Research Institutions, Others

This research report (Global Acquired Cystic Kidney Disease Treatment Dr) investigates and analyzes the current status and outlook for the global market of acquired cystic kidney disease treatment drugs over the next five years. It includes information on the overview of the global acquired cystic kidney disease treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antibiotics, non-steroidal anti-inflammatory drugs, and others, while the segments by application focus on hospitals, clinics, research institutions, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for acquired cystic kidney disease treatment drugs. It also includes the market share of major companies in the acquired cystic kidney disease treatment drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Solar Keratosis

[Research Material] The Global Market for Treatment of Solar Keratosis

World Market for the Treatment of Sunlight (Solar) Keratosis: 854-A, ACT-01, AD-17137, Celecoxib, DFD-08, GDC-695 ...

This research report (Global Actinic (Solar) Keratosis Treatment Market) investigates and analyzes the current status and outlook for the global market for solar keratosis treatment over the next five years. It includes information on the overview of the global solar keratosis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the solar keratosis treatment market include 854-A, ACT-01, AD-17137, celecoxib, DFD-08, GDC-695, and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for solar keratosis treatment. It also includes the market share of major companies in solar keratosis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Sleep Paralysis Treatment

[Research Material] The Global Market for Sleep Paralysis Treatment

Global Market for Sleep Paralysis Treatment: Stimulants, Selective Serotonin Reuptake Inhibitors (SSRIs), Tricyclic Antidepressants, Sodium Oxybate, Disease ...

This research report (Global Sleep Paralysis Treatment Market) investigates and analyzes the current state and outlook for the global market for sleep paralysis treatment over the next five years. It includes information on the overview of the global sleep paralysis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include stimulants, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and sodium oxybate, while the segments by application focus on hospitals, home care, care centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for sleep paralysis treatment. It also includes the market share of major companies in sleep paralysis treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.